Alberta Investment Management Corp (AIMCo)’s Alexion Pharmaceuticals ALXN Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-182,793	Closed	-$33.6M	–	1104
2021 Q2	$33.6M	Buy	182,793 +75,709	+71%	+$13M	0.28%	78
2021 Q1	$16.4M	Buy	107,084 +43,584	+69%	+$6.74M	0.15%	149
2020 Q4	$9.92M	Buy	+63,500	New	+$8.16M	0.09%	262
2020 Q3	–	Sell	-10,500	Closed	-$1.18M	–	1198
2020 Q2	$1.18M	Sell	10,500 -1,600	-13%	-$170K	0.01%	610
2020 Q1	$1.09M	Hold	12,100	–	–	0.02%	554
2019 Q4	$1.31M	Sell	12,100 -53,000	-81%	-$5.67M	0.01%	600
2019 Q3	$6.38M	Buy	+65,100	New	+$7.34M	0.06%	288
2018 Q3	–	Sell	-4,300	Closed	-$534K	–	926
2018 Q2	$534K	Buy	+4,300	New	+$503K	﹤0.01%	697
2018 Q1	–	Sell	-4,200	Closed	-$502K	–	845
2017 Q4	$502K	Buy	+4,200	New	+$511K	﹤0.01%	640
2017 Q2	–	Sell	-32,000	Closed	-$3.88M	–	870
2017 Q1	$3.88M	Buy	+32,000	New	+$4.13M	0.03%	344
2016 Q4	–	Sell	-45,900	Closed	-$5.63M	–	834
2016 Q3	$5.63M	Buy	+45,900	New	+$5.91M	0.06%	267
2016 Q2	–	Sell	-47,000	Closed	-$6.54M	–	703
2016 Q1	$6.54M	Buy	47,000 +25,700	+121%	+$3.77M	0.09%	208
2015 Q4	$4.06M	Buy	21,300 +1,400	+7%	+$245K	0.05%	372
2015 Q3	$3.11M	Buy	19,900 +5,554	+39%	+$1.01M	0.04%	397
2015 Q2	$2.59M	Buy	+14,346	New	+$2.48M	0.03%	422

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ALXN Position: Q3 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 182,793 shares — an estimated $33.6M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ALXN in Q2 2015 and held it in 15 quarters. The position peaked at $33.6M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Alberta Investment Management Corp (AIMCo) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 182,793 Alexion Pharmaceuticals shares in Q3 2021, an estimated $33.6M.
Alberta Investment Management Corp (AIMCo) first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 15 quarters.
Alberta Investment Management Corp (AIMCo)'s Alexion Pharmaceuticals position peaked at $33.6M in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2021, filed 15 Nov 2021.